Economiic Home Method Watch Market RSI Search

NLS Pharmaceutics AG NLSP

Sector:

Healthcare

Industry:

Biotechnology

Description:

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
NLS Pharmaceutics AG website

Recent Quarter:

2024-08-21

Upcoming Quarter:

N/A

Annual Reports

Date2024-05-15
Revenue 0
Net Income -12,172,029
EPS -0.32
Basic Shares 38,176,020
Diluted Shares 38,176,020
Report Link
Date2023-05-05
Revenue 0
Net Income -16,495,680
EPS -0.84
Basic Shares 19,682,643
Diluted Shares 19,682,643
Report Link
Date2022-03-24
Revenue 0
Net Income -11,946,078
EPS -0.81
Basic Shares 14,748,536
Diluted Shares 14,748,536
Report Link
Date2021-05-14
Revenue 0
Net Income -2,861,435
EPS -0.59
Basic Shares 4,819,277
Diluted Shares 4,819,277
Report Link
Date2019-12-31
Revenue 0
Net Income -5,447,145
EPS -0.49
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2018-12-31
Revenue 0
Net Income -5,146,766
EPS -0.44
Basic Shares 11,779,277
Diluted Shares 11,779,277
Report Link
Date2017-12-31
Revenue 0
Net Income -6,657,127
EPS -0.57
Basic Shares 11,779,277
Diluted Shares 11,779,277
Report Link

Annual Ratios

Date2023-12-31
PE -73.77
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -61.57
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -54.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -194.70
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -236.45
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -264.57
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -204.55
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-10-18
Revenue 0
Net Income -2,035,834
EPS -0.0485
Basic Shares 41,945,280
Diluted Shares 41,945,280
Report Link
Date2024-05-15
Revenue 0
Net Income -4,559.29
EPS -0.1406
Basic Shares 32,428,893
Diluted Shares 32,428,893
Report Link
Date2023-06-30
Revenue 0
Net Income -7,612,739
EPS -0.2
Basic Shares 38,176,020
Diluted Shares 38,176,020
Report Link
Date2023-05-05
Revenue 0
Net Income -7,854,871
EPS -0.29
Basic Shares 26,683,387
Diluted Shares 26,683,387
Report Link
Date2022-10-11
Revenue 0
Net Income -8,640,809
EPS -0.54
Basic Shares 15,892,327
Diluted Shares 15,892,327
Report Link
Date2022-03-24
Revenue 0
Net Income -7,342,736
EPS -0.5
Basic Shares 14,748,536
Diluted Shares 14,748,536
Report Link
Date2021-09-28
Revenue 0
Net Income -4,603,342
EPS -0.42
Basic Shares 11,069,254
Diluted Shares 11,069,254
Report Link
Date2021-05-14
Revenue 0
Net Income -1,629,219
EPS -0.34
Basic Shares 4,819,277
Diluted Shares 4,819,277
Report Link
Date2020-06-30
Revenue 0
Net Income -1,232,216
EPS -0.11
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2019-12-31
Revenue 0
Net Income -2,031,891
EPS -0.18
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2019-06-30
Revenue 0
Net Income -3,415,254
EPS -0.31
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2018-12-31
Revenue 0
Net Income -3,071.094
EPS -0.2756
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2018-06-30
Revenue 0
Net Income -2,075.672
EPS -0.1863
Basic Shares 11,141,817
Diluted Shares 11,141,817
Report Link
Date2018-03-31
Revenue 0
Net Income -1,286,691.5
EPS -0.12
Basic Shares 10,596,363
Diluted Shares 10,596,363
Report Link
Date2017-06-30
Revenue 0
Net Income -1,664,281.75
EPS -0.16
Basic Shares 10,596,363
Diluted Shares 10,596,363
Report Link
Date2017-03-31
Revenue 0
Net Income -1,664,281.75
EPS -0.16
Basic Shares 10,596,363
Diluted Shares 10,596,363
Report Link

Quarterly Ratios

Date2024-06-30
PE -40.43
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -41822.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -55.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -43.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -10.80
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -22.30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -75.50
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -85.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -261.32
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -158.47
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -94.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -104848.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -155129.77
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE -238.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-06-30
PE -184.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-03-31
PE -184.00
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

35.92

Price:

$3.18

Market Cap:

7,862,359

EPS TTM:

-0.68

PE Ratio:

-67.63

PEPSG:

NaN

Fwd PE:

NaN

Volume:

210,051

2 Year Price Change

0.155

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: